Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medicine and Health Sciences (2)
- Pharmacology (2)
- Pharmacology, Toxicology and Environmental Health (2)
- Amino Acids, Peptides, and Proteins (1)
- Biochemistry (1)
-
- Biotechnology (1)
- Cancer Biology (1)
- Cell and Developmental Biology (1)
- Chemicals and Drugs (1)
- Immunology and Infectious Disease (1)
- Macromolecular Substances (1)
- Molecular and Cellular Neuroscience (1)
- Neuroscience and Neurobiology (1)
- Other Immunology and Infectious Disease (1)
- Other Neuroscience and Neurobiology (1)
- Other Plant Sciences (1)
- Pharmaceutics and Drug Design (1)
- Pharmacy and Pharmaceutical Sciences (1)
- Plant Sciences (1)
- Keyword
-
- Cancer (2)
- Aminotransferase (1)
- Antibody (1)
- Biotechnology (1)
- Breast (1)
-
- Drug development (1)
- GlyRα1, GlyRα2, GlyRα3, GlyRα4 (1)
- Glycine receptor kinetics (1)
- HIV (1)
- Inhibitory retinal circuits (1)
- Lectin (1)
- NSCLC (1)
- Non-small cell lung carcinoma (1)
- PON2 (1)
- PSAT (1)
- Paraoxonase 2 (1)
- Phosphoserine (1)
- Plant-based protein expression (1)
- RAAV (1)
- ShRNA (1)
- Starburst amacrine cell (1)
Articles 1 - 4 of 4
Full-Text Articles in Molecular Biology
Investigation Of Phosphoserine Aminotransferase 1(Psat1) In Breast Cancer Progression., Stephanie Metcalf
Investigation Of Phosphoserine Aminotransferase 1(Psat1) In Breast Cancer Progression., Stephanie Metcalf
Electronic Theses and Dissertations
This dissertation describes my research into the involvement of phosphoserine aminotransferase 1 (PSAT1) in breast cancer progression; specifically, in triple negative breast cancer (TNBC) metastasis and endocrine resistance in estrogen receptor positive breast cancer (ER+BC). Breast cancer is the most common tumor diagnosis among women. While the overall 5-year survival for breast cancer is reaching 90%, the 5-year survival for metastatic disease is only 22%. Metastasis and endocrine resistance combined can affect over 50% of patients. One of the proteins and pathways implicated in both metastasis and endocrine resistance in breast cancer is phosphoserine aminotransferase 1 (PSAT1) and the serine …
Glycine Receptor Expression Across Identified Retinal Ganglion Cell Types., Ian Scot Pyle
Glycine Receptor Expression Across Identified Retinal Ganglion Cell Types., Ian Scot Pyle
Electronic Theses and Dissertations
Retinal ganglion cells (RGCs) represent the culmination of all retinal signaling and their output forms the substrate for vision throughout the rest of the brain. About 40 different RGC types have been defined by differences in their visually evoked responses, morphology, and genetic makeup. These responses arise from interactions between inhibition and excitation throughout the retinal circuit (Franke et al., 2017; Masland, 2012; Sanes & Masland, 2015; Werblin, 2011). Unlike most other areas of the central nervous system (CNS), the retina utilizes both GABA and glycine inhibitory neurotransmitters to refine glutamatergic excitatory signals (Franke & Baden, 2017; Werblin, 2011; C. …
Paraoxonase 2 Is Critical For Non-Small Cell Lung Carcinoma Proliferation., Aaron Whitt
Paraoxonase 2 Is Critical For Non-Small Cell Lung Carcinoma Proliferation., Aaron Whitt
Electronic Theses and Dissertations
Non-small cell lung carcinoma (NSCLC) comprises 85% of lung cancer diagnoses and is plagued by drug resistance. Thus, elucidating the underlying mechanisms of NSCLC is paramount to expand future treatment options. Paraoxonase 2 (PON2), an intracellular enzyme with arylesterase and lactonase functions, has well-established anti-atherosclerotic activity. Recent studies show PON2 is overexpressed in a variety of tumors and confers drug resistance, although these interactions have not been thoroughly examined in NSCLC. Thus, we sought to investigate the role of PON2 in cellular proliferation using PON2-knockout mice, primary mouse cells, and NSCLC cell lines. Using these approaches, we demonstrate that PON2 …
Development Of A Lectin-Fc Fusion Protein With Antiviral And Anti-Cancer Activity., Matthew William Dent
Development Of A Lectin-Fc Fusion Protein With Antiviral And Anti-Cancer Activity., Matthew William Dent
Electronic Theses and Dissertations
This thesis describes the development of a novel lectin-Fc fusion protein and its antiviral and anti-cancer activity. The molecule, Avaren-Fc (AvFc), is a fusion of a variant of the actinomycete lectin actinohivin (Avaren) and the Fc region of human IgG1, and is selective for the terminal α1,2-mannose residues found at the ends of high-mannose-type glycans that can be found on the surface of certain heavily glycosylated viruses and cancer cells. Here, AvFc was found to be able to neutralize simian immunodeficiency virus as well as Hepatitis C virus with nanomolar IC50 values. Furthermore, AvFc recognizes a number of cell …